AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lipocine Inc. Director's Dealing 2021

Jun 10, 2021

Director's Dealing

Opens in your device viewer

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2021-06-09

Reporting Person: Fink Jeffrey Arvin (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-09	Stock Option (Right to Buy)	$1.26	A	22000	Acquired	2031-06-09	Common Stock (22000)	Direct

F1: 100% vesting one year from date of grant